Skip to content
Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
Profitability
Gross margin60.7%+3.0pp59.3%-0.4pp57.2%-5.1pp56.7%-5.3pp57.7%-2.3pp
Operating margin23.7%+2.3pp23%-3.9pp20.7%-11.5pp18.4%-17.0pp21.4%-12.4pp
Net margin9.4%+2.8pp8.1%-2.9pp7.7%-7.1pp5.1%-12.2pp6.6%-9.8pp
Returns
Return on equity27.4%+8.2pp23.7%-8.9pp23%-19.9pp16.2%-31.7pp19.2%-27.2pp
Return on invested capital172.1%+17.8pp125.6%68.1%103.6%154.3%
Efficiency
Asset turnover0.5×0.0×0.5×0.0×0.5×0.0×0.5×0.0×0.5×0.0×
Liquidity
Current ratio1.7×+0.6×1.6×+0.6×1.4×+0.4×1.2×+0.1×1.1×-0.1×
Leverage
Debt-to-equity0.0×0.0×0.0×0.0×0.0×
Net debt / EBITDA-1.1×-0.8×-1×-0.8×-0.5×-0.4×-0.4×+0.1×-0.3×+0.3×
Per Share
Book value per share$7.80+9.2%$7.53+31.9%$6.97+19.5%$5.94+10.8%$7.14+33.1%
Valuation
Market capitalization$1.15B+20.4%$1.46B+58.4%$1.1B-11.4%$967.8M-8.1%$959.13M-22.7%
Price / earnings15.4×-6.4×23.3×+9.9×18.9×+4.8×26.7×+16.1×21.9×+8.6×
Price / sales1.5×0.0×1.9×+0.4×1.5×-0.6×1.4×-0.5×1.4×-0.7×
Price / book3.7×-0.4×4.9×+0.8×-1.3×4.2×-0.7×4.1×-1.5×
EV / EBITDA3.5×+1.0×5.1×+2.6×3.5×0.0×+0.4×2.6×-0.5×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Collegium Pharmaceutical, Inc.'s profit margins?
Collegium Pharmaceutical, Inc. (COLL) runs a 60.7% gross margin and a 23.7% operating margin, with a 9.4% net margin.
Where do Collegium Pharmaceutical, Inc.'s ratios come from?
Every ratio is computed from Collegium Pharmaceutical, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.